Discovery of serum biomarkers in astrocytoma by SELDI-TOF MS and proteinchip technology

Journal of Neuro-Oncology

Volumn 84, Issue 3, 2007, Pages 315-323

  Zhang, Haishi ^a   Wu, Gang ^a   Tu, Hong ^b   Huang, Fengping ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Astrocytoma; Biological markers; Proteinchip array; Proteomics; Serum

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ARTICLE; ASTROCYTOMA; BLOOD SAMPLING; BRAIN LYMPHOMA; BRAIN METASTASIS; BRAIN TUMOR; CATION EXCHANGE; CAVERNOUS HEMANGIOMA; CLINICAL TRIAL; COMPUTER PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFERENTIAL DIAGNOSIS; DOWN REGULATION; FEMALE; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN MICROARRAY; PROTEOMICS; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; UPREGULATION;

ASTROCYTOMA; BRAIN NEOPLASMS; COMPUTATIONAL BIOLOGY; HUMANS; PROTEIN ARRAY ANALYSIS; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 34547144723     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-007-9376-5     Document Type: Article

References (18)

1. Merchant M, Weinberger SR (2000) Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis 21:1164-1177
2. Wiesner A (2004) Detection of tumor markers with proteinchip technology. Curr Pharm Biotechnol 5(1):45-67
3. Bast RC Jr (2003) Status of tumor markers in ovarian cancer screening. J Clin Oncol 21(10 Suppl):200-205
4. Cazares LH, Adam BL, Ward MD, Nasim S, Schellhammer PF, Semmes OJ, Wright GLJ (2002) Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by Surface Enhanced Laser Desorption/Ionization mass spectrometry. Clin Cancer Res 8(8):2541-2552
5. Mannes AJ, Martin BM, Yang HY, Keller JM, Lewin S, Gaiser RR, Iadarola MJ (2003) Cystatin C as a cerebrospinal fluid biomarker for pain in humans. Pain 102(3):251-256
6. Li J, Zhang Z, Rosenzweig J, Wang YY, Chan DW (2002) Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 48:1296-1304
7. Srinivas PR, Verma M, Zhao Y, Srivastava S, Clark RA, Tockman MS (2002) Proteomics for cancer biomarker discovery. Clin Chem 48(8):1160-1169
8. Hutchens TW, Yip TT (1993) New desorption stratefies for the mass spectrometric analysis of macromolecules. Rapid Commun Mass Spectrum 7:576-580
9. Adam BL, Qu Y, Davis JW, Ward MD, Clements MA, Cazares LH, Semmes OJ, Schellhammer PF, Yasui Y, Feng Z, Wright GL Jr (2002) Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benigh prostate gyperplasia and healthy men. Cancer Res 62:3609-3614
10. Petricoin EF 3rd, Ornstein DK, Paweletz CP, Ardekani A, Hackett PS, Hitt BA, Velassco A, Trucco C, Wiegand L, Wood K, Simone CB, Levine PJ, Linehan WM, Emmert-Buck MR, Steinberg SM, Kohn EC, Liotta LA (2002) Serum proteomic patterns for detection of prostate cancer. J Nat Cancer Inst 94:1576-1578
11. Xiao Z, Adam BL, Cazares LH, Clements MA, Davis JW, Schellhammer PF, Dalmasso EA, Wright GL Jr (2001) Quantitation of serum prostate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate disease. Cancer Res 61:6029-6033
12. Vlahou A, Schellhammer PF, Mendrinos S, Patel K, Kondylis FI, Gong L, Nasim S, Wright GL Jr (2001) Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. Am J Pathol 158:1491-1502
13. Bandera CA, Ye B, Mok SC (2003) New technologies for the identification of markers for early detection of ovarian cancer. Curr Opin Obstet Gynecol 15:51-55
14. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC, Liotta LA (2002) Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359:572-577
15. Coombes KR, Fritsche HA Jr, Clarke C, Chen JN, Baggerly KA, Morris JS, Xiao LC, Hung MC, Kuerer HM (2003) Quality control and peak finding for proteomics data collected from nipple aspirate fluid by surface-enhanced laser desorption and ionization. Clin Chem 49:1615-1623
16. Xiao XY, Tang Y, Wei XP, He DC (2003) A preliminary analysis of non-small cell lung cancer biomarkers in serum. Biomed Environ Sci 16:140-148
17. Rosty C, Christa L, Kuzdzal S, Baldwin WM, Zahurak ML, Carnot F, Chan DW, Canto M, Lillemoe KD, Cameron JL, Yeo CJ, Hruban RH, Goggins M (2002) Identification of Hepatocarcinoma-Intestine-Pancreas/Pancreatitis - associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. Cancer Res 62:1868-1875
18. Pauleit D, Floeth F, Hamacher K, Riemenschneider MJ, Reifenberger G, Muller HW, Zilles K, Coenen HH, Langen KJ (2005) O-(2-[18F]fluoroethyl)- l-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas. Brain 128:678-687